v3.26.1
STOCKHOLDERS' EQUITY AND EQUITY INCENTIVE PLANS (Tables)
 6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Schedule of Share-Based Payment Arrangement, Option, Activity
A summary of the Company's stock option activity with respect to options granted under the 2021 Plan is as follows:

Number of Options
Weighted
Average exercise price
Weighted remaining contractual term (years)Aggregate
Intrinsic
Value








Outstanding as of January 1, 2026

13,615,770$3.37 3.76$1,582 


Granted

— $— 
Exercised

(225,114)$0.25 $269 
Forfeited

(4,360,153)$4.52 
Outstanding and exercisable as of June 30, 2026

9,030,503$2.90 2.90$823 
Schedule of Share-Based Payment Arrangement, Restricted Stock Unit, Activity
The following table summarizes the RSU activity with respect to the 2021 Plan for the six months ended June 30, 2026:


RSUs
Outstanding

Weighted Average
Grant Date Fair
Value per Share
Outstanding as of December 31, 2025

9,635,959$2.16
RSUs granted

7,037,000$1.39
RSUs vested

(3,773,787)$1.99
RSUs forfeited

(280,099)$2.13
Unvested and Outstanding as of June 30, 2026

12,619,073$1.78
Schedule Of Share-Based Payment Arrangement, Cost by Plan
The stock-based compensation expense by line item in the accompanying consolidated statement of operations is summarized as follows:
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Cost of revenue$102 $119 $208 $247 
Research and development1,033 760 2,046 1,609 
Sales and marketing753 383 1,236 815 
General and administrative1,852 2,829 4,010 5,953 
Total expenses$3,740 $4,091 $7,500 $8,624 
Schedule Of Shares Of Common Stock Reserved For Future Issuance
The Company has the following common stock reserved for future issuance under the 2021 Plan:
June 30, 2026
Outstanding options9,030,503 
Outstanding RSUs12,619,073 
Shares reserved under 2021 Plan12,322,908 
Total33,972,484